Abstract:BackgroundAdverse Drug Reactions (ADRs) are of great public health concern. FDA-approved drug labeling summarizes ADRs of a drug product mainly in three sections, i.e., Boxed Warning (BW), Warnings and Precautions (WP), and Adverse Reactions (AR), where the severity of ADRs are intended to decrease in the order of BW>WP>AR. Several reported studies have extracted ADRs from labeling documents, but most, if not all, did not discriminate the severity of the ADRs by the different labeling sections. Such a practice could overstate or underestimate the impact of certain ADRs to the public health. In this study, we applied the Medical Dictionary for Regulatory Activities (MedDRA) to drug labeling and systematically analyzed and compared the ADRs from the three labeling sections with a specific emphasis on analyzing serious ADRs presented in BW, which is of most drug safety concern.ResultsThis study investigated New Drug Application (NDA) labeling documents for 1164 single-ingredient drugs using Oracle Text search to extract MedDRA terms. We found that only a small portion of MedDRA Preferred Terms (PTs), 3819 out of 21,920 or 17.42%, were observed in a whole set of documents. In detail, 466/3819 (12.0%) PTs were in BW, 2023/3819 (53.0%) were in WP, and 2961/3819 (77.5%) were in AR sections. We also found a higher overlap of top 20 occurring BW PTs with WP sections compared to AR sections. Within the MedDRA System Organ Class levels, serious ADRs (sADRs) from BW were prevalent in Nervous System disorders and Vascular disorders. A Hierarchical Cluster Analysis (HCA) revealed that drugs within the same therapeutic category shared the same ADR patterns in BW (e.g., nervous system drug class is highly associated with drug abuse terms such as dependence, substance abuse, and respiratory depression).ConclusionsThis study demonstrated that combining MedDRA standard terminologies with data mining techniques facilitated computer-aided ADR analysis of drug labeling. We also highlighted the importance of labeling sections that differ in seriousness and application in drug safety. Using sADRs primarily related to BW sections, we illustrated a prototype approach for computer-aided ADR monitoring and studies which can be applied to other public health documents.

Design and implement of ADR auto-monitoring system based on HIS and LIS

The Adverse Drug Reaction Monitoring in Hospitals

[A Study on the LIS and HIS Integration].

Study of Serious Adverse Drug Reactions Using FDA-approved Drug Labeling and MedDRA

Identification of Adverse Drug Events in Chinese Clinical Narrative Text

A Knowledge Base Driven Clinical Pharmacist Information System

Optimization of Monitoring and Reporting System of Adverse Drug Reaction in Medical Organizations

Establishment of a Rapid Identification of Adverse Drug Reaction Program in R Language Implementation Based on Monitoring Data

Adverse drug reactions reported to liver injury in China: Database and reporting outlines

Establishment of quantitative signal detection system on adverse drug reaction spontaneous reporting database of Shanghai

The Role of Pharmacists in ADR Monitoring Mode of "physician Reporting, Pharmacist Assisting"

2008-2011 Adverse Drug Reaction Analysis of 490 Cases in Huadong Hospital

Analysis on 115 Cases of ADR Reports in Our Hospital

Study on Construction and Development of Primary Adverse Drug Reaction Monitoring System in China

Detection of adverse drug reactions in transfusion patients

The application of PDCA cycle in ADR teaching program and evaluation of its effect

Quality Analysis of the Adverse Drug Reactions Reports from Shanghai Healthcare Professionals

An Improved Algorithm for ADR Signal Detection and Its Application to Shanghai Spontaneous ADR Reporting System

ADRs monitoring and analysis of cardiovascular drugs

Interactive crowdsourcing to spontaneous reporting of Adverse Drug Reactions

Literature Analysis on Adverse Drug Reaction in China